OBJECTIVE: The purpose of this study was to evaluate trajectories of and predictors for changes in upper extremity (UE) function in women (n = 396) during the first year after breast cancer treatment. DESIGN: Prospective, longitudinal assessments of shoulder range of motion (ROM), grip strength, and perceived interference of function were performed before and for 1 year after surgery. Demographic, clinical, and treatment characteristics were evaluated as predictors of postoperative function. RESULTS: Women had a mean (SD) age of 54.9 (11.6) years, and 64% were white. Small but statistically significant reductions in shoulder ROM were found on the affected side over 12 months (P < 0.001). Predictors of interindividual differences in ROM at the 1-month assessment were ethnicity, neoadjuvant chemotherapy, type of surgery, axillary lymph node dissection, and preoperative ROM. Predictors of interindividual differences in changes over time in postoperative ROM were living alone, type of surgery, axillary lymph node dissection, and adjuvant chemotherapy. Declines in mean grip strength from before through 1 month after surgery were small and not clinically meaningful. Women with greater preoperative breast pain interference scores had higher postoperative interference scores at all postoperative assessments. CONCLUSION: Some of the modifiable risk factors identified in this study can be targeted for intervention to improve UE function in these women.
OBJECTIVE: The purpose of this study was to evaluate trajectories of and predictors for changes in upper extremity (UE) function in women (n = 396) during the first year after breast cancer treatment. DESIGN: Prospective, longitudinal assessments of shoulder range of motion (ROM), grip strength, and perceived interference of function were performed before and for 1 year after surgery. Demographic, clinical, and treatment characteristics were evaluated as predictors of postoperative function. RESULTS:Women had a mean (SD) age of 54.9 (11.6) years, and 64% were white. Small but statistically significant reductions in shoulder ROM were found on the affected side over 12 months (P < 0.001). Predictors of interindividual differences in ROM at the 1-month assessment were ethnicity, neoadjuvant chemotherapy, type of surgery, axillary lymph node dissection, and preoperative ROM. Predictors of interindividual differences in changes over time in postoperative ROM were living alone, type of surgery, axillary lymph node dissection, and adjuvant chemotherapy. Declines in mean grip strength from before through 1 month after surgery were small and not clinically meaningful. Women with greater preoperative breast pain interference scores had higher postoperative interference scores at all postoperative assessments. CONCLUSION: Some of the modifiable risk factors identified in this study can be targeted for intervention to improve UE function in these women.
Authors: Maria Kyranou; Steven M Paul; Laura B Dunn; Kathleen Puntillo; Bradley E Aouizerat; Gary Abrams; Deborah Hamolsky; Claudia West; John Neuhaus; Bruce Cooper; Christine Miaskowski Journal: Eur J Oncol Nurs Date: 2012-08-11 Impact factor: 2.398
Authors: Christine Miaskowski; Steven M Paul; Bruce Cooper; Claudia West; Jon D Levine; Charles Elboim; Deborah Hamolsky; Gary Abrams; Judith Luce; Anand Dhruva; Dale J Langford; John D Merriman; Kord Kober; Christina Baggott; Heather Leutwyler; Bradley E Aouizerat Journal: Eur J Oncol Nurs Date: 2014-01-29 Impact factor: 2.398
Authors: Barbara A Springer; Ellen Levy; Charles McGarvey; Lucinda A Pfalzer; Nicole L Stout; Lynn H Gerber; Peter W Soballe; Jerome Danoff Journal: Breast Cancer Res Treat Date: 2010-02 Impact factor: 4.872
Authors: Christina Van Onselen; Bradley E Aouizerat; Laura B Dunn; Steven M Paul; Claudia West; Deborah Hamolsky; Kathryn Lee; Michelle Melisko; John Neuhaus; Christine Miaskowski Journal: Breast Date: 2012-08-01 Impact factor: 4.380
Authors: Linda Koehler; Amanda Day; David Hunter; Anne Blaes; Tufia Haddad; Ryan Shanley Journal: Arch Phys Med Rehabil Date: 2022-04-06 Impact factor: 4.060
Authors: Seoyon Yang; Dae Hwan Park; Sei Hyun Ahn; Jisun Kim; Jong Won Lee; Jun Young Han; Dong Kyu Kim; Jae Yong Jeon; Kyoung Hyo Choi; Won Kim Journal: Support Care Cancer Date: 2016-12-09 Impact factor: 3.603
Authors: Ahmet Akbas; Hasan Dagmura; Emin Daldal; Fatih Mehmet Dasiran; Hülya Deveci; Ismail Okan Journal: Breast Care (Basel) Date: 2020-04-14 Impact factor: 2.860
Authors: Helena Harder; Patrick Holroyd; Lynn Burkinshaw; Phil Watten; Charles Zammit; Peter R Harris; Anna Good; Val Jenkins Journal: J Cancer Surviv Date: 2017-07-24 Impact factor: 4.442
Authors: Elizabeth A Chrischilles; Danielle Riley; Elena Letuchy; Linda Koehler; Joan Neuner; Cheryl Jernigan; Brian Gryzlak; Neil Segal; Bradley McDowell; Brian Smith; Sonia L Sugg; Jane M Armer; Ingrid M Lizarraga Journal: Breast Cancer Res Treat Date: 2019-03-09 Impact factor: 4.872
Authors: Nur Amalina Che Bakri; Richard M Kwasnicki; Kieran Dhillon; Naairah Khan; Omar Ghandour; Alexander Cairns; Ara Darzi; Daniel R Leff Journal: Ann Surg Oncol Date: 2021-07-26 Impact factor: 5.344